ZA200305590B - Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders. - Google Patents

Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders.

Info

Publication number
ZA200305590B
ZA200305590B ZA200305590A ZA200305590A ZA200305590B ZA 200305590 B ZA200305590 B ZA 200305590B ZA 200305590 A ZA200305590 A ZA 200305590A ZA 200305590 A ZA200305590 A ZA 200305590A ZA 200305590 B ZA200305590 B ZA 200305590B
Authority
ZA
South Africa
Prior art keywords
preventing
amino acids
gastrointestinal disorders
visceral pain
bicyclic amino
Prior art date
Application number
ZA200305590A
Other languages
English (en)
Inventor
Maria Chovet
Laurent Diop
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200305590B publication Critical patent/ZA200305590B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200305590A 2001-01-26 2003-07-18 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders. ZA200305590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01400214A EP1226820A1 (en) 2001-01-26 2001-01-26 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ZA200305590B true ZA200305590B (en) 2004-10-18

Family

ID=8182608

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200305590A ZA200305590B (en) 2001-01-26 2003-07-18 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders.
ZA200407412A ZA200407412B (en) 2001-01-26 2004-09-15 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200407412A ZA200407412B (en) 2001-01-26 2004-09-15 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders.

Country Status (22)

Country Link
US (2) US6784208B2 (pl)
EP (3) EP1226820A1 (pl)
JP (2) JP2004517147A (pl)
KR (1) KR20030070140A (pl)
CN (1) CN1610544A (pl)
AR (1) AR036009A1 (pl)
AT (1) ATE293968T1 (pl)
BR (1) BR0206687A (pl)
CA (1) CA2435950A1 (pl)
DE (1) DE60203878T2 (pl)
DK (1) DK1357910T3 (pl)
ES (1) ES2240686T3 (pl)
IL (2) IL164012A0 (pl)
MX (1) MXPA03006723A (pl)
NZ (1) NZ526625A (pl)
PE (1) PE20020832A1 (pl)
PL (1) PL363354A1 (pl)
PT (1) PT1357910E (pl)
SI (1) SI1357910T1 (pl)
TW (1) TWI223593B (pl)
WO (1) WO2002058680A2 (pl)
ZA (2) ZA200305590B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60235619D1 (de) * 2001-04-19 2010-04-22 Warner Lambert Co Kondensierte bizyklische oder trizyklische aminosäuren
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
EP1032555B1 (en) * 1997-10-27 2006-04-12 Warner-Lambert Company Llc Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
EP1031350A1 (en) * 1999-02-23 2000-08-30 Warner-Lambert Company Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
DE60235619D1 (de) * 2001-04-19 2010-04-22 Warner Lambert Co Kondensierte bizyklische oder trizyklische aminosäuren

Also Published As

Publication number Publication date
ZA200407412B (en) 2005-06-29
US6784208B2 (en) 2004-08-31
DE60203878D1 (de) 2005-06-02
PE20020832A1 (es) 2002-10-03
PL363354A1 (pl) 2004-11-15
US20040266876A1 (en) 2004-12-30
AR036009A1 (es) 2004-08-04
IL156667A0 (en) 2004-01-04
BR0206687A (pt) 2004-02-03
PT1357910E (pt) 2005-08-31
SI1357910T1 (pl) 2005-08-31
JP2005015492A (ja) 2005-01-20
ES2240686T3 (es) 2005-10-16
EP1514541A1 (en) 2005-03-16
NZ526625A (en) 2004-12-24
IL164012A0 (en) 2005-12-18
US20020161047A1 (en) 2002-10-31
CN1610544A (zh) 2005-04-27
DE60203878T2 (de) 2006-02-16
EP1226820A1 (en) 2002-07-31
WO2002058680A3 (en) 2002-09-19
EP1357910B1 (en) 2005-04-27
KR20030070140A (ko) 2003-08-27
EP1357910A2 (en) 2003-11-05
TWI223593B (en) 2004-11-11
WO2002058680A2 (en) 2002-08-01
MXPA03006723A (es) 2003-10-24
CA2435950A1 (en) 2002-08-01
ATE293968T1 (de) 2005-05-15
DK1357910T3 (da) 2005-08-08
JP2004517147A (ja) 2004-06-10

Similar Documents

Publication Publication Date Title
EP1578988A4 (en) TNF-ALPHA VARIANT-BASED PROTEIN FOR TREATMENT OF TNF-ALPHA ASSOCIATED DISORDERS
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
AU5714601A (en) Methods for prevention and treatment of gastrointestinal disorders
EP1455778A4 (en) METHODS OF TREATING PERIPHERAL NEUROVASCULAR MALAYS
AU2002351397A8 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2003286611A8 (en) Cytomodulating peptides and methods for treating neurological disorders
IL187030A0 (en) Use of retigabine for the treatment of neuropathic pain
IL160389A0 (en) Use of flibanserin for the treatment of sexual disorders
HUP0400005A3 (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
AU4541101A (en) Design and discovery of protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
PL376894A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
AU2003268295A8 (en) "diagnosis and treatment of infertility"
GB0213869D0 (en) The treatment of pain
ZA200305590B (en) Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders.
PL376895A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
HUP0303306A3 (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease
AU2002362115A8 (en) Composition and methods for treatment of neurological disorders
PL361629A1 (pl) Stosowanie aminokwasów do zwalczania bólu
GB0128674D0 (en) Treatment of sleep disorders and the like
HK1062806A1 (en) Novel methods for the treatment and prevention of pain using stress- activated protein kinase inhibitors
GB0100092D0 (en) Treatment of degenerative diseases
GB0120253D0 (en) Treatment of neuroinflammatory disease
GB0216978D0 (en) The treatment of pain